Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HMPL-012

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Purpose: No antiangiogenic treatment is yet approved for extrapancreatic neuroendocrine tumors (NET). Surufatinib (HMPL-012… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3